Loading...
XJPX
9987
Market cap2.09bUSD
Jul 10, Last price  
4,938.00JPY
1D
-1.75%
1Q
-18.14%
Jan 2017
29.27%
Name

Suzuken Co Ltd

Chart & Performance

D1W1MN
XJPX:9987 chart
P/E
8.76
P/S
0.13
EPS
563.83
Div Yield, %
1.99%
Shrs. gr., 5y
-4.76%
Rev. gr., 5y
3.16%
Revenues
2.49t
+3.61%
1,454,841,000,0001,586,596,000,0001,641,331,000,0001,735,476,000,0001,751,928,000,0001,859,917,000,0001,894,611,000,0001,988,137,000,0001,969,683,000,0002,228,204,000,0002,127,076,000,0002,124,016,000,0002,132,345,000,0002,213,532,000,0002,128,478,000,0002,239,112,000,0002,314,828,000,0002,386,493,000,0002,399,952,000,0002,486,647,000,000
Net income
38.14b
+10.55%
17,701,000,00021,327,000,0007,072,000,00013,969,000,0009,627,000,0008,050,000,00014,350,000,00021,447,000,00018,920,000,00028,960,000,00021,309,000,00018,821,000,00030,205,000,00028,213,000,0007,896,000,00014,394,000,00020,345,000,00029,016,000,00034,497,000,00038,136,000,000
CFO
33.57b
P
68,115,000,000-16,118,000,000-4,585,000,00031,913,000,00028,336,000,00065,542,000,00054,006,000,000-41,054,000,00047,209,000,00020,457,000,00027,013,000,00098,066,000,00041,751,000,000-25,817,000,00015,602,000,0009,520,000,00037,270,000,00087,216,000,000-65,079,000,00033,566,000,000
Dividend
Sep 29, 202660 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a global wholesaler of pharmaceutical products, with a strong presence both in Japan and internationally. The company's diverse activities are structured into four main divisions: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy Services, and Healthcare-Related Services. The Pharmaceutical Distribution segment focuses on sourcing a wide array of items, including prescription medications, diagnostic substances, various medical devices and supplies, and other health-focused goods directly from manufacturers. These products are then supplied to medical facilities and pharmacies. In its Pharmaceutical Manufacturing division, Suzuken engages in the research, development, production, and marketing of ethical pharmaceuticals and diagnostic tools, with a particular emphasis on treatments for diabetes and kidney diseases. Through its Pharmacy Services segment, the company provides support via community pharmacists, while also striving to optimize the operations of local pharmacies and offering essential educational assistance. Finally, the Healthcare-Related Services division offers a broad spectrum of functions. This includes providing support for manufacturers, such as outsourced distribution and the specialized distribution of orphan drugs, in addition to delivering nursing care services. This segment is also responsible for the design, manufacturing, and sale of medical instruments like ECG machines, blood pressure monitors, and stethoscopes, as well as general medical materials and equipment for health promotion. Beyond these core business areas, Suzuken Co., Ltd. also publishes medical periodicals specifically for healthcare professionals and institutions. The company has also forged a strategic alliance with Bushu Pharmaceuticals Ltd. to offer specialized contract drug services. Suzuken Co., Ltd. was established in 1932 and is headquartered in Nagoya, Japan.
IPO date
Aug 01, 1994
Employees
13,429
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT